Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Fear Free Pets Announces Expansion into the United Kingdom with Harrison Family Vets


“Just like with humans, a pet can’t be optimally healthy unless they’re also happy,” said Dr Becker “Fear, anxiety, and stress (FAS) in life raises the levels of hormones that are destructive to both the body and mind. Fear Free uses clinically proven protocols to remove or reduce FAS triggers, it takes steps to mitigate FAS so that the pet feels safe and calm during a veterinary visit. The worst thing for a pet parent to feel is that they’re ‘hurting their pet by trying to help them’. In a Fear Free Certified Veterinary Practice, we ‘take the pet out of petrified and put the treat into treatment’. Expect tails to wag and cats to purr.”

“The certification of Harrison Family Vets is a fantastic way for Fear Free to announce their formal expansion into the UK, New Zealand and Australia,” said Randy Valpy, Fear Free’s CEO. “For years individual veterinary staff have been able to become certified, but they have had to pay in US dollars and there wasn’t a mechanism for practices to become certified. With a simplified pricing structure for practice certification and a new website launching in early 2024 we will be promoting our programs using local currencies.”

The practice certification process took Harrison Family Vets several months to achieve. Group Clinical Director, James Harris, who led the project outlined “The message behind Fear Free in protecting the emotional well-being of pets under our care fitted easily with our own beliefs. Taking this to the next level required an open and honest team conversation, development of realistic protocols and a subtle change in behaviours to ensure we always put the pet first within a supportive work environment”. On the resource needed to achieve certification, he added “Most of the changes have been doing things differently rather than actually doing more”. Initially Harrison Family Vets had committed to certifying every single one of its team, clinical and non-clinical, but wanted to go a stage further. Yvette Rowntree, Clinic Director at Reading, commented “We are so proud to have been the first of what we hope will be many certified practices in the UK. Working in a truly committed Fear Free environment makes such a difference to the pets we treat”. Kristie Faulkner concluded “When we first learned about Fear Free from a former American colleague, we were told that it is a superior way to practice. Having adopted it, we now believe this completely and hope that for the benefit of all pets, many other practices will follow our lead”.

“We are absolutely thrilled to have Harrison Family Vets as our first UK Fear Free Certified Veterinary Practice” said Dr Jennifer Merlo, Fear Free’s Director of Veterinary Affairs, “We now plan to certify further practices in the UK and beyond providing veterinary professionals with the knowledge and techniques to practice quality medicine while showing consideration for patient’s emotional health as well.”

The Fear Free team will be attending London Vet Show in November and Dr Becker will be presenting on how Fear Free radically changes companion animal practice and the benefits to pets, people, and practice.

About Harrison Family Vets

Harrison Family Vets were established in 2021. They are a family owned independent group, with three generations of the Harrison family currently working in the group. They currently operate five practices in Reading, Dudley, Didsbury, Stockton, and Doncaster. They aim to open a further five practices in 2024 and aim to have in excess of thirty practices across the country by the end of the decade.

About Fear Free

Founded by Dr Marty Becker and developed by hundreds of experts in behaviour, medicine, and handling, Fear Free offers online and in-person education to veterinary professionals, the pet professional community, animal shelter staff and volunteers, and pet owners. Fear Free provides both professionals and pet lovers alike with the knowledge and tools to look after a pet’s physical and emotional wellbeing.

Veterinary or pet professionals can learn more about becoming Fear Free Certified by visiting fearfreepets.com. Pet owners can visit fearfreehappyhomes.com to access free videos, articles, and more that will help improve the physical and emotional health of their pets right at home. Shelter, rescue, and animal welfare employees and volunteers can visit fearfreeshelters.com to enrol in the complimentary program.

Contact:

For Harrison Family Vets
Kristie Faulkner
[email protected]
07435 983401

For Fear Free
Andru Valpy
[email protected]
001 (USA) 416-399-0082

SOURCE Fear Free

The Definitive Guide by Victoria Ferrara


Ferrara opens the book with a history of surrogacy in the United States and then leads the readers through the extraordinary ethical framework of gestational surrogacy as it is done in the United States. Further on, Ferrara meticulously explains the various stages of the surrogacy journey in detail that will assist all intended parents to organize their thoughts and plans to have children through surrogacy. As Dr. Doyle asserts, this book is authored by “one of the most trusted and admired surrogacy attorneys in the United States.”

The book is geared to gestational surrogates as well as intended parents, in that it gives thoughtful consideration to what surrogates need to know about the surrogacy process and what they should look for in choosing a surrogacy agency that will properly support them in this profound endeavor.

Attorney Ferrara is the Founder and Legal Director of Worldwide Surrogacy Specialists, LLC, one of the foremost and leading surrogacy agencies in the world. She incorporates her thirty plus years of legal practice in assisted reproduction technology law as legal advisor to the many intended parents she represents. Ferrara changed the law in Connecticut when she argued the case of Raftopol v Ramey before the Supreme Court of Connecticut. This precedent-setting case paved the way for all intended parents, genetic or non-genetic, straight or gay, to become legal parents of their babies by way of a pre-birth order of legal parentage. In sum, Ferrara created a new way to become a legal parent.

Ferrara is a member of the Academy of Adoption and Assisted Reproduction Attorneys, the American Society for Reproductive Medicine, the American Bar Association Family Law Section, and the National LGBTQ+ Bar Association’s Family Law Group. She was awarded the LAMBDA Award for Outstanding LGBTQ+ Community Service, as well as the Mid-Fairfield AIDS Project President’s Award since she was the President of this organization in the 1980s.She frequently lectures and presents as a panelist at international surrogacy conferences, universities, and professional seminars all over the world.

For anyone in the fertility field, and for all intended parents looking toward surrogacy as a family formation option, as well as for women considering the path of becoming a gestational surrogate, Ferrara’s book is a must read. Available now at Amazon and other online bookstores.

Media Contact

Victoria T Ferrara, Worldwide Surrogacy Specialists, LLC, 1 2034519863 2034519863, [email protected], www.worldwidesurrogacy.org

SOURCE Worldwide Surrogacy Specialists, LLC

Alexandria, VA’s , Dr. Hye Park Achieves Prestigious Designation as Diplomate of the American Board of Dental Sleep Medicine


More about Hye Park, DMD:

Dr. Park is a diplomat of the American Board of Dental Sleep Medicine who is a talented general, cosmetic and biological dentist who believes in using superior, patient-centered care while placing strong value on the connection between oral health and overall health. In doing so, her goal is to provide the best individualized dental care in the healthiest, safest and most holistic way possible through a whole-body approach. Green Dental of Alexandria accepts many dental insurance plans and offers flexible financing and in-house payment options. At Northern Virginia Sleep Solutions, Dr. Park provides advanced sleep apnea treatment as a CPAP alternative to give the quality sleep that patients need for optimal health. Green Dental of Alexandria and Northern Virginia Sleep Solutions are located at 1725 Duke St., Suite GR03, in Alexandria, Virginia. For more information, please visit http://www.greendentalalexandria.com or call (703)-549-1725 and http://www.novasleepsolutions.com or call (571)-290-7977.

Media Contact

Dr. Hye Park, Green Dental of Alexandria, (703) 549-1725, [email protected], https://greendentalalexandria.com/

SOURCE Green Dental of Alexandria

Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative AI Technology


Densitas intelliMammo® will provide actionable information to clinical care teams, managers, and administrators when and where it is needed by leveraging the international scale of Intelerad’s IntelePACS® diagnostic imaging and PenRad® breast imaging reporting systems. This partnership will deliver a unique end-to-end solution for breast imaging facilities.

“We are thrilled to announce our strategic partnership with Densitas® to offer intelliMammo® to healthcare providers, equipping them with sophisticated decision-making support and superior mammography quality improvement solutions,” said Morris Panner, President of Intelerad. “We are committed to supplying our customers with best-in-class solutions that not only ensure top-quality patient care but also enhance workflow efficiency. The introduction of intelliMammo® alongside our existing PenRad® breast imaging reporting system reinforces our strategic focus on women’s health.”

intelliMammo® is a mammography enterprise software platform that comprises AI engines that generate breast density, mammography positioning quality, and breast cancer risk assessments that support enhanced workflows and continuous mammography quality improvement. Actionable insights from advanced analytics support better patient care, increased operational efficiencies, and strengthened compliance with FDA MQSA EQUIP and American College of Radiology (ACR) standards for mammography facilities.

intelliMammo® densityAI™ is a deep learning algorithm that generates standardized and automated breast density assessments from mammograms that align with the ACR BI-RADS® breast tissue composition density scale.

intelliMammo® intelliPGMI™ is an AI-based mammography positioning quality score that provides standardized and automated quality assessments of mammograms.

intelliMammo® riskVue™ delivers breast cancer risk assessments from select breast cancer risk models.

About Densitas
Densitas is a global leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency, and precision breast health. intelliMammo® supports hospitals and imaging centers delivering mammography services to improve efficiencies, meet FDA/ACR compliance requirements, and support early breast cancer detection and treatment. For more information, visit densitashealth.com.

About Intelerad
Intelerad is one of the leading providers of medical imaging software and services for the healthcare industry. Headquartered in Raleigh, NC, and Montreal, Quebec, Intelerad has over 900 employees located in offices across six countries. Nearly 2,500 healthcare organizations around the world rely on Intelerad products to manage patient data, helping them reduce time and workload while improving patient outcomes. Intelerad’s award-winning enterprise imaging solutions have been recognized globally by KLAS, with Intelerad’s Ambra Health ranked #1 in Image Exchange for eight consecutive years. To learn more, visit intelerad.com.

Media Contact

Hollie Barnidge, Alloy on behalf of Intelerad, (855) 300-8209, [email protected], https://www.intelerad.com/en/ 

SOURCE Intelerad

Synterex Launches its AgileWriter™ Clinical Document Development Tool


AgileWriter can input a variety of source formats, extracting essential information and integrating rich biochemistry knowledge to craft documents in natural language while presenting information at a reading level suitable to the public. It is also one of the only medical communications tools built by design to adhere to the W3C® Authoring Tool Accessibility Guidelines (ATAG), maximizing the intersection between technology and accessibility.

“Plain language clinical and regulatory documents take time to generate—in some cases weeks—which is valuable time that clinical trial sponsors and sites need to get their study started,” said Synterex President Jeanette Towles. “AgileWriter can accelerate the document creation process, helping to get new treatments to patients faster and more efficiently. Every day a patient waits for a therapy they need is a day too long. Furthermore, for every day a drug is not on the market, it can cost a company millions of dollars; our tool can help companies reinvest that time and money into their R&D.”

AgileWriter evolves with each use, incorporating feedback to self-optimize. Its flexibility will extend to trial protocols, investigator brochures, data reports, and even regulatory submissions. It is an all-in-one tool designed for today’s demanding clinical landscape.

To learn more about the features of AgileWriter, click here: https://synterex.com/agilewriter/, or email [email protected].

For more information on Synterex and its leadership, visit: www.synterex.com.

About Synterex, Inc.:

Synterex is a woman-owned, disability-owned clinical and regulatory consulting firm specializing in agile-based project management methodology, automation, and AI-driven technologies. Delivering quality regulatory documentation requires navigating an evolving landscape influenced by regulators, research committees, healthcare professionals, and—most importantly—the scientific method itself.

At Synterex, we forge lasting and meaningful relationships that flex with the dynamic nature of science and technology.

Media Contact

Jeanette Towles, Synterex, 1 888-760-9906, [email protected], https://synterex.com/

SOURCE Synterex

Nanovis Surpasses 500th Surgery Utilizing Nanotechnology Designated Screws


Nanovis celebrates this significant milestone as it continues to commercialize nanotechnology and improve patient outcomes.

COLUMBIA CITY, Ind., Oct. 17, 2023 /PRNewswire-PRWeb/ — Nanovis, a pioneer in nanotechnology solutions, is thrilled to announce the successful completion of its 500th surgery using the groundbreaking FortiFix™ pedicle screws. This milestone is not just a numeric achievement but a testament to the innovative application of FDA-designated nanotechnology, ensuring enhanced patient recovery and surgical success.

FortiFix™ pedicle screws, distinguished as the first FDA-cleared pedicle screw with a nanotechnology designation, have demonstrated a remarkable track record in facilitating biologic fixation that increases and accelerates bone-to-implant interface for osseointegration. Over 3,000 pedicle screws have been implanted in the initial 500 surgeries, with patients experiencing positive outcomes, including no known infections or non-fusions noted in the Maude database. The system has proven its efficacy across a spectrum of surgeries, including degenerative, deformity, trauma, and revision surgeries.

Dr. Todd Bonvallet, from Atlanta, GA, shares his experience: “To address the risk of pseudoarthrosis, or the failure of bone fusion to occur as intended, I have incorporated Nanovis’ nanotechnology implants to support rapid bone growth on and through the fusion construct. Utilizing Nanovis nanotechnology pedicle screws (nano FortiFix™) over the last 18 months has yielded impressive results, promoting rapid osseointegration and leading to faster and more complete fusion.”

Nanovis’ commitment to advancing spinal surgery with nanotechnology is further echoed by surgeon Dr. Wade Ceola, from Glenwood Springs, CO, who has witnessed firsthand the positive impact of nano FortiCore™ interbodies in the cervical spine over several years, and now, nano FortiFix™ pedicle screws in the lumbar spine. “The early bone ongrowth observed with the use of FortiFix™ pedicle screws not only improves healing but also ensures stronger fixation, enhancing the overall stability and success of spinal surgeries.”

“Our vision is to Enable and Engage – Enable innovation that will Engage health care and patients. With over a decade of research, we have demonstrated the biological advantages of our nanoVIS Ti Surface Technology™. Since 2019, we have had 7 spinal devices cleared by the FDA with a nanotechnology designation, including the first ever PEEK Titanium Hybrid Interbodies (nano FortiCore™) and the first ever Open and MIS pedicle screw systems (nano FortiFix™). Since the clearance of our nano FortiFix™ pedicle screw systems, I am astounded by the positive feedback we get from surgeons on their experience with the product and how the nanotechnology is helping patients heal,” states Nanovis CEO, Brian More.

More continued with his statement saying, “Medtronic’s implementation of nanotechnology, as evidenced in their recent clearance of their nanoLOCK™ surface technology on pedicle screws, validates our position that nanotechnology is clinically advancing beyond the interbody space. In this rapidly changing world of device surface technology, we should not be satisfied with traditionally manufactured implants when our nanoVIS Ti Surface Technology™ solution is truly making a difference in the lives of patients.”

Nanovis will be showcasing the nano FortiFix™ pedicle screws at the NASS 38th Annual Meeting in Los Angeles, CA, at Booth #1111 from October 18-21, 2023.

To read more about Dr. Bonvallet’s experiences with nanoVIS Ti Surface Technology™, click here.

To read more about Dr. Ceola’s experiences with nanoVIS Ti Surface Technology™, click here.

Ready to learn more about the science behind nanoVIS Ti Surface Technology™? Join us on LinkedIn.

About Nanovis

Nanovis is a technology-driven company committed to discovering unmet clinical needs, developing innovative and enabling solutions, and validating new technologies for clinical and market acceptance. The company, through its subsidiary Nanovis Spine, has successfully commercialized its proprietary nanoVIS Ti Surface Technology™ across a range of spinal implants, including the nano FortiFix™ Pedicle Screws and Nano FortiCore™ PEEK Titanium Hybrid Interbodies, the latter being enriched with OsteoSync™ technology licensed from Sites Medical.

Notably, the nanoVIS Ti Surface Technology™ platform is showing potential in pre-clinical studies to evolve into an antimicrobial surface in select markets, while concurrently, Nanovis is innovating a next-generation antimicrobial technology aimed at combating localized infections across various applications, including skin, transcutaneous devices, and orthopedic implants.

Media Contact

Guillaume Viallaneix, MedTech Momentum, 1 (407) 960-2994, [email protected], medtechmomentum.com

SOURCE Nanovis

Building a Winning Life Science Eco-system


Watch this unique webinar to discover how Life Science organizations can a combine a best-in-class platform with freedom of solution choice to improve product quality, productivity and supply chain continuity.

Join Joe Goodman, Global VP Solutions Engineering and Customer Engagement, Honeywell; and J Cris Salinas, MD, Industry Advisor, HLS, Salesforce, for the live webinar on Wednesday, November 01, 2023, at 11am EDT (4pm CET/EU-Central).

For more information, or to register for this event, visit Building a Winning Life Science Eco-system – Leveraging the Quality Link between Platform, Processes and Patients.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Transforming Drug Discovery, Upcoming Webinar Hosted by Xtalks


Noor will discuss how AI can rapidly predict pharmacological properties. By integrating AI with DEL and proprietary data, drug hunters can be equipped with powerful new capabilities. Ultimately, the goal is a faster and more efficient discovery of high-quality leads. The combination of rich data from DEL and the predictive power of AI stands to greatly accelerate the timeline from initial screening to pre-clinical candidates.
Join this webinar to learn how these powerful capabilities can be integrated and put into the hands of drug hunters to accelerate the process from screen to candidate.

Join Noor for the live webinar on Wednesday, November 1, 2023, at 10am EDT (3pm CET/EU-Central).

For more information, or to register for this event, visit AI and DNA-Encoded Libraries Synergy: Transforming Drug Discovery.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Regulatory & Technology Perspectives, Upcoming Webinar Hosted by Xtalks


  •     The use of ML to augment and complement the use of animal models in preclinical research
  •     Techniques supporting improved preclinical toxicological knowledge and toxicogenomic research
  •     Applying chemical pattern analysis and bioanalytics to predict drug interactions and support drug repositioning
  •     Concepts of bias and explainability in preclinical AI model development

Join Dr. Szczepan Baran, MS, VMD, CSO, VeriSIM Life; and Dr. Weida Tong, PhD, Director, Division of Bioinformatics and Biostatistics, FDA National Center for Toxicological Research, for the live webinar on Monday, October 30, 2023, at 1pm EDT (5pm GMT/UK).

For more information, or to register for this event, visit AI in Biomedical Research: Regulatory & Technology Perspectives.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks